Giudice, E., Huang, T., Nair, J. R., Zurcher, G., McCoy, A., Nousome, D., . . . Lee, J. The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: A phase 2 trial. Nature Portfolio.
Chicago Style (17th ed.) CitationGiudice, Elena, et al. The CHK1 Inhibitor Prexasertib in BRCA Wild-type Platinum-resistant Recurrent High-grade Serous Ovarian Carcinoma: A Phase 2 Trial. Nature Portfolio.
MLA (9th ed.) CitationGiudice, Elena, et al. The CHK1 Inhibitor Prexasertib in BRCA Wild-type Platinum-resistant Recurrent High-grade Serous Ovarian Carcinoma: A Phase 2 Trial. Nature Portfolio.
Warning: These citations may not always be 100% accurate.